Beta-blockers in COPD: A systematic review based on recent research
- 7 April 2020
- journal article
- review article
- Published by Elsevier BV in Life Sciences
- Vol. 252, 117649
- https://doi.org/10.1016/j.lfs.2020.117649
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational StudyPLOS ONE, 2013
- Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohortRespiratory Medicine, 2013
- Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Beta-blocker use and COPD mortality: a systematic review and meta-analysisBMC Pulmonary Medicine, 2012
- New insights into the immunology of chronic obstructive pulmonary diseaseThe Lancet, 2011
- Effect of blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort studyBMJ, 2011
- β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary DiseaseArchives of Internal Medicine, 2010
- Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiologyEuropean Journal of Heart Failure, 2009
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEuropean Respiratory Journal, 2008